Search hospitals > Kentucky > Lexington
Central Kentucky Research Associates, Inc.
Claim this profileLexington, Kentucky 40509
Global Leader in Flu
Conducts research for Smoking
Conducts research for Type 2 Diabetes
Conducts research for Coronavirus
Conducts research for Tobacco Chewing
128 reported clinical trials
3 medical researchers
Summary
Central Kentucky Research Associates, Inc. is a medical facility located in Lexington, Kentucky. This center is recognized for care of Flu, Smoking, Type 2 Diabetes, Coronavirus, Tobacco Chewing and other specialties. Central Kentucky Research Associates, Inc. is involved with conducting 128 clinical trials across 135 conditions. There are 3 research doctors associated with this hospital, such as Mark Adams, Richard M. Glover II, and Richard M Glover, MD.Area of expertise
1Flu
Global Leaderestrogen
ER
2Smoking
Top PIs
Mark AdamsAlliance for Multispecialty Research, LLC4 years of reported clinical research
Studies Smoking
Studies Tobacco Chewing
19 reported clinical trials
35 drugs studied
Richard M. Glover IIAlliance for Multispecialty Research, LLC1 year of reported clinical research
Studies Chronic Kidney Disease
Studies Cardiovascular Disease
2 reported clinical trials
3 drugs studied
Richard M Glover, MDHeartland Research Associates2 years of reported clinical research
Studies Nonalcoholic Steatohepatitis
Studies Non-alcoholic Fatty Liver Disease
2 reported clinical trials
2 drugs studied
Clinical Trials running at Central Kentucky Research Associates, Inc.
Type 2 Diabetes
Cardiovascular Disease
Atherosclerosis
Coronavirus
COVID-19
Birth Control
Vestibular Migraine
Migraine
Dyslipidemias
Heart Disease
Retatrutide
for Obesity
The main purpose of this study is to determine if retatrutide can significantly lower the incidence of serious heart-related complications or prevent the worsening of kidney function. The trial will enroll adults with body mass index 27 kg/m\^2 or higher and Atherosclerotic Cardiovascular Disease and/or chronic kidney disease. The study will last for about 5 years. Participants will have up to 27 clinic visits with the study doctor.
Recruiting1 award Phase 32 criteria
MK-2828
for Type 2 Diabetes
The purpose of this study is to learn about the safety and if people tolerate a study medicine called MK-2828. The study will also measure what happens to MK-2828 in the body of a person with type 2 diabetes (T2D) over time (pharmacokinetic or PK study), and how it affects the amount of high-sensitivity C-reactive protein (hsCRP) in a person's blood.
Recruiting0 awards Phase 12 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Central Kentucky Research Associates, Inc.?
Central Kentucky Research Associates, Inc. is a medical facility located in Lexington, Kentucky. This center is recognized for care of Flu, Smoking, Type 2 Diabetes, Coronavirus, Tobacco Chewing and other specialties. Central Kentucky Research Associates, Inc. is involved with conducting 128 clinical trials across 135 conditions. There are 3 research doctors associated with this hospital, such as Mark Adams, Richard M. Glover II, and Richard M Glover, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.